liv12173-sup-0001-FileS1.docWord document166KData S1. Supplemental Data for LiverAtlas.
liv12173-sup-0002-FigureS1.tifimage/tif1564KFig. S1. Overlap of HuLDO and other disease vocabularies.
liv12173-sup-0003-FigureS2.tifimage/tif1550KFig. S2. Cellular component distribution of liver-and HCC-significant genes/proteins.
liv12173-sup-0004-FigureS3.tifimage/tif3787KFig. S3. Immunohistochemical staining for BMP7, BMP4, and MYO6.
liv12173-sup-0005-FigureS4.tifimage/tif1255KFig. S4. Correlation of degree and K value vs fractions of known cancer genes.
liv12173-sup-0006-TableS1.docWord document39KTable S1. BMP7, BMP4, and MYO6 expression.
liv12173-sup-0007-TableS2.docWord document29KTable S2. Detailed information of two microarray datasets.
liv12173-sup-0008-TableS3.docWord document75KTable S3. Clinicopathologic variables of HCC patients.
liv12173-sup-0009-TableS4.docWord document39KTable S4. LTBR, CD55, INHBE, and SP100 expression.
liv12173-sup-0010-TableS5.docWord document248KTable S5. List of up- and down-regulated genes as candidate markers.
liv12173-sup-0011-TableS6.docWord document29KTable S6. Topological feature values of candidate HCC markers.
liv12173-sup-0012-TableS7.docWord document31KTable S7. Detail information of these genes.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.